A retrospective study of occurrence of intolerability in multiple sclerosis patients treated with interferon beta and glatiramer acetate
Latest Information Update: 14 Dec 2021
At a glance
- Drugs Glatiramer acetate (Primary) ; Interferon beta (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 14 Dec 2021 New trial record
- 15 Oct 2021 Results presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis